Kamada Ltd. (Nasdaq and TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces that it will release its financial results for the fourth quarter and full year ended December 31, 2013 prior to the market open on Wednesday, February 5, 2014.
Help employers find you! Check out all the jobs and post your resume.
